H. Nakagawa

发表

Late infantile Hirschsprung disease–mental retardation syndrome with a 3-bp deletion in ZFHX1B

N. Wakamatsu, M Nagaya, M. Kishikawa, 2002, Neurology.

High prevalence of serum autoantibodies against the amino terminal of α-enolase in Hashimoto's encephalopathy

M. Yoneda, A. Fujii, H. Nakagawa, 2007, Journal of Neuroimmunology.

[A steroid-responsive case of severe rhabdomyolysis associated with cytomegalovirus infection].

I. Higuchi, Keishiro Sato, M. Yoneda, 2006, Rinsho shinkeigaku = Clinical neurology.

HMG‐CoA reductase inhibitor‐induced L6 myoblast cell death: involvement of the phosphatidylinositol 3‐kinase pathway

H. Nakagawa, T. Mutoh, M. Kuriyama, 1998, FEBS letters.

Cloning of rat lysosomal acid lipase cDNA and identification of the mutation in the rat model of Wolman's disease.

M. Osame, H. Nakagawa, M. Kuriyama, 1995, Journal of lipid research.

Myopathy induced by HMG-CoA reductase inhibitors in rabbits: a pathological, electrophysiological, and biochemical study.

M. Osame, K. Nakahara, I. Higuchi, 1998, Toxicology and applied pharmacology.

HMG-CoA reductase inhibitor induces a transient activation of high affinity nerve growth factor receptor, Trk, and morphological differentiation with fatal outcome in PC12 cells

H. Nakagawa, M. Kuriyama, T. Mutoh, 2000, Brain Research.

A new mutation (LIPA Tyr22X) of lysosomal acid lipase gene in a Japanese patient with Wolman disease

H. Sakuraba, M. Osame, H. Nakagawa, 1996 .

Gastric dysmotility associated with accumulation of mitochondrial A3243G mutation in the stomach.

T. Azuma, M. Ohtani, M. Yoneda, 2004, Internal medicine.

Purification of two species of exudate cysteine‐proteinase inhibitors that are acute‐phase reactants in the carrageenin‐induced inflammation in rats

H. Nakagawa, K. Hirata, H. Nakagawa, 1986, FEBS letters.

Hashimoto encephalopathy presenting with progressive cerebellar ataxia

M. Yoneda, A. Fujii, H. Nakagawa, 2009, BMJ Case Reports.

Hashimoto’s encephalopathy presenting with progressive cerebellar ataxia

M. Yoneda, A. Fujii, H. Nakagawa, 2007, Journal of Neurology, Neurosurgery & Psychiatry.

Blood Dolichols in a Patient with Abetalipoproteinaemia

M. Osame, K. Nakahara, H. Nakagawa, 1999, Annals of clinical biochemistry.

Unique clinicopathological features and PrP profiles in the first autopsied case of dura mater graft-associated Creutzfeldt–Jakob disease with codon 219 lysine allele observed in Japanese population

N. Miyashita, H. Naiki, T. Kitamoto, 2009, Journal of the Neurological Sciences.

Involvement of tyrosine phosphorylation in HMG‐CoA reductase inhibitor‐induced cell death in L6 myoblasts

H. Nakagawa, T. Mutoh, M. Kuriyama, 1999, FEBS letters.

Tyrosine phosphorylation of the catalytic subunit p110 of phosphatidylinositol‐3 kinase induced by HMG‐CoA reductase inhibitor inhibits its kinase activity in L6 myoblasts

H. Nakagawa, M. Kuriyama, T. Kumano, 2001, FEBS letters.

Improvement of apraxia of eyelid opening by wearing goggles

H. Nakagawa, M. Hirayama, T. Aita, 2000, The Lancet.

[Thiamine deficiency polyneuropathy after gastrectomy associated with high level of serum vascular endothelial growth factor (VEGF). A case report].

M. Yoneda, H. Nakagawa, M. Kuriyama, 2004, Rinsho shinkeigaku = Clinical neurology.